Risk factors and treatment of relapses in autoimmune pancreatitis: Rituximab is safe and effective

Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients with Autoimmune Pancreatitis: Systematic Review and Meta-analysis

(2018) Matteo Tacelli et al.   Clinical Gastroenterology and Hepatology

International consensus for the treatment of autoimmune pancreatitis

(2017) Kazuichi Okazaki et al.   PANCREATOLOGY

Azathioprine Maintenance Therapy to Prevent Relapses in Autoimmune Pancreatitis

(2017) Nicolò de Pretis et al.   Clinical and Translational Gastroenterology

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

(2017) Mikael Ebbo et al.   PLoS One

Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis

(2016) Atsushi Masamune et al.   GUT

Clonal expansion of CD4 + cytotoxic T lymphocytes in patients with IgG 4 -related disease

(2016) Hamid Mattoo et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease

(2014) Hamid Mattoo et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011

(2014) Hisanori Umehara et al.   Modern Rheumatology

The clinical course of patients with IgG4-related kidney disease

(2013) Takako Saeki et al.   KIDNEY INTERNATIONAL

Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients

(2012) Ronald F van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis

(2012) Phil A Hart et al.   GUT

Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience

(2012) Phil A Hart et al.   GUT

Rituximab for the Treatment of IgG4-Related Disease

(2011) Arezou Khosroshahi et al.   MEDICINE

International Consensus Diagnostic Criteria for Autoimmune Pancreatitis

(2011) Tooru Shimosegawa et al.   PANCREAS

Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis

(2010) Frédérique Maire et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Two Clinicopathologic Subtypes of Autoimmune Pancreatitis: LPSP and IDCP

(2010) Terumi Kamisawa et al.   GASTROENTEROLOGY

Differences in Clinical Profile and Relapse Rate of Type 1 Versus Type 2 Autoimmune Pancreatitis

(2010) Raghuwansh P. Sah et al.   GASTROENTEROLOGY

Presentation and Management of Post-treatment Relapse in Autoimmune Pancreatitis/Immunoglobulin G4-Associated Cholangitis

(2009) Neomal S. Sandanayake et al.   Clinical Gastroenterology and Hepatology

Standard steroid treatment for autoimmune pancreatitis

(2009) T Kamisawa et al.   GUT

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

(2009) Laurent Beaugerie et al.   LANCET

Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy

(2008) Amaar Ghazale et al.   GASTROENTEROLOGY